| Product Name | MF | CAS | Details |
|---|
| Il5 Blocking Peptide | Details |
| Ethyl pyrrolidine-2-carboxylate | C7H13NO2 | 60169-67-7 | Details |
| 2-Chloro-5-nitrocinnamic acid | C9H6ClNO4 | 36015-19-7 | Details |
| 2-Chloro-5-nitrobenzoic acid | C7H4ClNO4 | 2516-96-3 | Details |
| 4-(2-Aminoethyl)-2-methoxyaniline | C9H14N2O | 180149-06-8 | Details |
| 2-(1-Methyl-1H-imidazol-2-yl)piperazine trihydrochloride | C8H15ClN4 | 1798700-80-7 | Details |
| Bis(trimethylsilyl)malonate | C9H20O4Si2 | 18457-04-0 | Details |
| HLA-A*02:01 Human RNA-dependent helicase YLLPAIVHI | Details |
| N-(4-chlorophenyl)(6-methyl(1,2,3,4-tetrahydroquinolyl))formamide | C17H17ClN2O | 894400-30-7 | Details |
| Piperaquine N-oxide | C29H32Cl2N6O | 925673-46-7 | Details |
| 3-Bromo-5-(trifluoromethyl)pyridin-4-amine | C6H4BrF3N2 | 1417622-88-8 | Details |
| 4-Ethoxy-4-methylpiperidine hydrochloride | C8H18ClNO | 1803585-86-5 | Details |
| endo-β-1,4-Mannanase | 37288-54-3 | Details |
| Anti-Mrgpre antibody R2G - 2mg/mL | Details |
| (R)-6-Fluoroindan-1-ylamine hydrochloride | C9H11ClFN | 731859-02-2 | Details |
| 1-(2-(2,2-dimethyl(3-oxaindan-4-yloxy))acetyl)-4-phenylsemicarbazide | C19H21N3O4 | 1023498-27-2 | Details |
| 2-Ethyl-2-(prop-2-en-1-yl)propane-1,3-diol | C8H16O2 | 27606-26-4 | Details |
| Methyl 2-cyano-4-(trifluoromethyl)benzoate | C10H6F3NO2 | 61500-86-5 | Details |
| Docosahexaenoic acid | C22H32O2 | 25167-62-8 | Details |
| AP2S1 antibody (biotin) | Details |
| C4ORF28 Blocking Peptide | Details |
| H-KK^V^VFKVKF^K^-NH2 | Details |
| 4-(Pyrrolidine-1-sulfonyl)-1H-pyrrole-2-carboxylic acid | C9H12N2O4S | 870693-08-6 | Details |
| 1-(3,5-bis(trifluoromethyl)phenyl)-3-benzoylthiourea | C16H10F6N2OS | 499197-64-7 | Details |
| 5-(Bromomethyl)-2-methylpyrimidin-4-amine hydrobromide | C6H9Br2N3 | 2908-71-6 | Details |
| 2-Phenoxybenzoic acid | C13H10O3 | 2243-42-7 | Details |
| 4-Trifluoromethylthiophenylboronic acid pinacol ester | C13H16BF3O2S | 1005206-25-6 | Details |
| H-DNEAYEMPSEEGYQD-NH2 | Details |
| H-SPGVAELSLR^-OH | Details |
| (S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate | C13H25NO5 | 81323-58-2 | Details |
| 1-bromo-2-chloro-4-fluoro-5-nitrobenzene | C6H2BrClFNO2 | 111010-08-3 | Details |
| Methyl 3,3-dimethyl-5-oxohexanoate | C9H16O3 | 68208-76-4 | Details |
| 2-Cyano-N,N-dimethylacetamide | C5H8N2O | 7391-40-4 | Details |
| KLK1 antibody | Details |
| 2-(4,5,6,7-Tetrahydro-1H-1,2,3-benzotriazol-1-yl)acetic acid hydrochloride | C8H11N3O2.HCl | 1803610-38-9 | Details |
| 4-Amino-3-(2-hydroxyethoxy)benzoic acid | C9H11NO4 | 1096862-98-4 | Details |
| Val-Val-Val-Gly-Ala-Asp-Gly-Val-Gly-Lys | Details |
| H-K^RPPGFSPF-OH | Details |
| 6,7-Dimethoxy-4-methylquinazoline | C11H12N2O2 | 4015-31-0 | Details |
| 4'-C-Fluoroadenosine | C10H12FN5O4 | 170874-47-2 | Details |
| {[5-(Furan-2-yl)-1,2-oxazol-3-yl]methyl}(methyl)amine hydrochloride | C9H11ClN2O2 | 857283-62-6 | Details |
| 2,2-Dimethylhexanal | C8H16O | 996-12-3 | Details |
| 4-Hydroxy atorvastatin disodium salt | C33H33FN2Na2O6 | 1276537-18-8 | Details |
| 2,5-Difluorobenzaldehyde | C7H4F2O | 2646-90-4 | Details |
| ethyl 2-(2-amino-1,3-thiazol-4-yl)benzenecarboxylate | C12H12N2O2S | 339010-09-2 | Details |
| ENO1 antibody | Details |
| NOTCH4 antibody | Details |
| 2-(3-Aminophenyl)-1-(4-methylpiperazin-1-yl)ethan-1-one | C13H19N3O | 1018525-88-6 | Details |
| (1R)-1-(2,5-Dimethylphenyl)ethan-1-amine | C10H15N | 77302-55-7 | Details |
| Dok-5 (263-275) | Details |
| 2,6-Dimethoxy-3-nitrobenzamide | C9H10N2O5 | 55776-15-3 | Details |
| 3-Methoxy-3-methyl-1-butanol | C6H14O2 | 56539-66-3 | Details |
| DAZAP1 Blocking Peptide | Details |
| (2-Chlorophenyl)(2,3-dihydro-1,4-benzodioxin-6-yl)methanamine | C15H14ClNO2 | 1019443-74-3 | Details |
| Firibastat | C8H20N2O6S4 | 648927-86-0 | Details |
| Methyl 4-amino-2-fluoro-5-nitrobenzoate | C8H7FN2O4 | 872871-50-6 | Details |
| Cyclopentyl(pyrimidin-2-yl)methanol | C10H14N2O | 1182977-20-3 | Details |
| Glutaryl-Phe-bNA | C24H24N2O4 | 17479-62-8 | Details |
| LMP2 (419-427), TYG | Details |
| (4-Amino-phenyl)-acetic acid methyl ester hydrochloride | C9H12ClNO2 | 83528-16-9 | Details |
| CRABP2 antibody | Details |
| Octan-2-ylhydrazine dihydrochloride | C8H21ClN2 | 1375473-75-8 | Details |
| cis-2-Aminocyclobutan-1-ol hydrochloride | C4H10ClNO | 2070860-49-8 | Details |
| 6-Bromo-2-(diethoxymethyl)-3H-imidazo[4,5-b]pyridine | C11H14BrN3O2 | 1498444-97-5 | Details |
| 2-(4-Methylphenyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine | C13H15N3 | 1547030-53-4 | Details |
| 2-[(Furan-2-ylmethyl)amino]-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one | C10H8N4O2S | 926247-29-2 | Details |
| C.I.Direct green 85 | C36H30N7NaO8S2 | 72390-60-4 | Details |
| 1-(2,3-Dihydro-1,4-benzodioxine-6-sulfonyl)piperazine | C12H16N2O4S | 95591-73-4 | Details |
| 3-((3-(Trifluoromethyl)phenyl)amino)cyclohex-2-en-1-one | C13H12F3NO | 51924-57-3 | Details |
| 2-Deoxy-D-arabino-hexose propylene dithioacetal | C9H18O4S2 | 91294-63-2 | Details |
| 4-Chloro-1H-inden-2(3H)-one | C9H7ClO | 74124-90-6 | Details |
| 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-β-D-thioglucopyranose | C16H23NO9S | 10043-46-6 | Details |
| Phospholipase D2 antibody | Details |
| 3-Nitro-N-phenylpyridin-4-amine | C11H9N3O2 | 35750-90-4 | Details |
| (4-(3-chloro-5-(trifluoromethyl)(2-pyridylthio))phenyl)(2-naphthylsulfonyl)amine | C22H14ClF3N2O2S2 | 1023540-33-1 | Details |
| Methyl-2-(2-amino-4-phenylthiazol-5-yl)acetate | C12H12N2O2S | 147003-46-1 | Details |
| 5-Methylthiophene-2-carbonitrile | C6H5NS | 72835-25-7 | Details |
| [4-(Oxolan-3-ylmethoxy)phenyl]boronic acid | C11H15BO4 | 1334399-57-3 | Details |
| 6-O-Sulphated Lewisa-BSA | Details |
| WFDC1 Blocking Peptide | Details |
| N,N-Dimethyl-1,2,3,4-tetrahydroisoquinolin-7-amine dihydrochloride | C11H17ClN2 | 1803565-88-9 | Details |
| 2-Chloro-N-methyl-N-[1-(3-nitrophenyl)ethyl]acetamide | C11H13ClN2O3 | 1423029-72-4 | Details |
| Recombinant Mouse IFN-gamma R1 | Details |
| (2S,4S)-4-Fluoro-2-(methanesulfonylmethyl)pyrrolidine hydrochloride | C6H13ClFNO2S | 2219353-67-8 | Details |
| Ro 08-2750 | C13H10N4O3 | 37854-59-4 | Details |
| HXB2 gag NO-30/aa117 - 131 | C59H94N22O26 | Details |
| Phosphorylated Protein Kinase C Substrate 2 | Details |
| 3-{Bicyclo[3.1.0]hexan-3-yl}-1,2-oxazol-5-amine | C9H12N2O | 1528854-60-5 | Details |
| H-SAPDNRPAL-OH | Details |
| 4-(Aminomethyl)-5-methyl-2H-1,3-dioxol-2-one hydrochloride | C5H8ClNO3 | 2230804-13-2 | Details |
| LHRH (7-10)·2 HCl | C19H37ClN8O4 | 75690-75-4 | Details |
| 3-(2-Hydroxyacetyl)benzonitrile | C9H7NO2 | 83112-50-9 | Details |
| 1-[(3-Chlorophenyl)methyl]piperazin-2-one hydrochloride | C11H13N2OCl.HCl | 1394041-02-1 | Details |
| CD136 antibody (Ser1394) | Details |
| Linamarin | C10H17NO6 | 554-35-8 | Details |
| 4-Phenyl-tetrahydro-pyran-4-ylamine | C11H15NO | 14006-31-6 | Details |
| ZFP91 Blocking Peptide | Details |
| SH3BGR Blocking Peptide | Details |
| Pyrimidine-2-carbohydrazide | C5H6N4O | 87362-28-5 | Details |
| Ifosfamide impurity A | C5H13ClNO4P | 22608-58-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 | ||||